Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€3.69

€3.69

19.020%
0.59
19.020%
€8.00
 
14:20 / Tradegate WKN: A2P71U / Name: Curevac / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Curevac N.V. Stock

A very strong showing by Curevac N.V. today, with an increase of €0.59 (19.020%) compared to yesterday's price.
Our community is currently high on Curevac N.V. with 4 Buy predictions and 0 Sell predictions.
With a target price of 8 € there is potential for a 116.68% increase which would mean more than doubling the current price of 3.69 € for Curevac N.V..
Our community identified positive and negative aspects for Curevac N.V. stock for the coming years. 19 users see the criterium "Worthwhile Investment for the next years" as a plus for the Curevac N.V. stock. On the other hand our users think that "General Risks" could be a problem in the future.

Pros and Cons of Curevac N.V. in the next few years

Pros
?
G***** c******* t* c**********
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Sell Curevac N.V.
Show more

Buy Curevac N.V.
Show more

Buy Curevac N.V.
Show more

News

EQS-News: CureVac Initiates Strategic Restructuring to Align Resources with  Focus on High-Value mRNA Pipeline Opportunities: https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
EQS-News: CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
EQS-News: CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
EQS-News: GSK and CureVac to Restructure Collaboration into New Licensing Agreement: https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
EQS-News: GSK and CureVac to Restructure Collaboration into New Licensing Agreement
EQS-News: GSK and CureVac to Restructure Collaboration into New Licensing Agreement
EQS-News: CureVac Announces Voting Results of General Meeting: https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
EQS-News: CureVac Announces Voting Results of General Meeting
EQS-News: CureVac Announces Voting Results of General Meeting